Investors Hub Daily
iHub My Stocks Activity
Ticker Buzz Cloud
Most Followed Members
Hot on StockWiki
My Image Gallery
Medicare pays for REPR's product and rejects everybody
Post New Msg
Saturday, June 23, 2012 7:52:19 PM
Medicare pays for REPR's product and rejects everybody else's. The "upgrade" pumps are electronic and multitudes more expensive which is probably why REPR's sales are exploding.
It is more unique than a snowflake. You have less of a clue what you're talking about than you had with ALIF when we went at it, and you were loading up 1.30+ screaming your head off that their massive accounts receivable problem was fine, stalking me to all sorts of other boards, and now is down 97%.
But to answer your questions...
1. Subcutaneous can be done easily at home by the patient at his or her lesiure or even while traveling where IV is typical done at a hospital or by an at home-nurse. It's always massively more expensive and inconvenient.
2. The ratio of people dropping IV and going to SC is accelerating rapidly and as been, due to #1.
3. The cost savings are far better with SC than IV.
Like I said, it's innovative, unqiue, and I don't have to "pump" it up. They are doing awesome by their own merits. I doubt you'd short it after you went dead broke on ALIF.
Research & analysis on some of my favorite stocks is located on the sticky note on the SwingTrade board.
Post New Msg
Report TOS Violation
+/- to Watchlist
© 2013 InvestorsHub.Com, Inc.
Terms of Service
Advertise With Us
Stock Market 101
Investor Help Forum
iHub on Facebook
iHub on Twitter
iHub iPhone/iPad App
iHub Android App